Insight Inv LLC Sells 6,195 Shares of Procter & Gamble Company (The) $PG

Insight Inv LLC cut its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 33.7% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,174 shares of the company’s stock after selling 6,195 shares during the period. Insight Inv LLC’s holdings in Procter & Gamble were worth $1,940,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kingstone Capital Partners Texas LLC raised its position in Procter & Gamble by 655,209.0% during the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Nuveen LLC purchased a new stake in Procter & Gamble during the first quarter valued at approximately $1,954,941,000. Price T Rowe Associates Inc. MD raised its position in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Invesco Ltd. raised its position in Procter & Gamble by 19.8% during the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company’s stock valued at $2,299,580,000 after purchasing an additional 2,228,151 shares during the period. Finally, Valeo Financial Advisors LLC raised its holdings in shares of Procter & Gamble by 1,875.5% in the second quarter. Valeo Financial Advisors LLC now owns 1,763,404 shares of the company’s stock worth $280,946,000 after buying an additional 1,674,139 shares during the period. 65.77% of the stock is owned by institutional investors.

Procter & Gamble Trading Down 1.2%

Shares of NYSE:PG opened at $150.67 on Thursday. The company has a market capitalization of $352.64 billion, a PE ratio of 23.14, a P/E/G ratio of 4.05 and a beta of 0.36. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12-month low of $149.91 and a 12-month high of $180.43. The business’s fifty day simple moving average is $155.26 and its 200-day simple moving average is $159.72.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter last year, the company earned $1.40 earnings per share. The firm’s revenue for the quarter was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Insider Transactions at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 13,039 shares of the company’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the transaction, the chief operating officer directly owned 28,036 shares of the company’s stock, valued at approximately $4,409,221.72. This represents a 31.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Andre Schulten sold 11,638 shares of the firm’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,830,308.26. Following the completion of the sale, the chief financial officer directly owned 52,642 shares of the company’s stock, valued at $8,279,007.34. The trade was a 18.11% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the company. UBS Group reduced their price target on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a report on Wednesday. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $170.00 price target (down from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. BNP Paribas Exane dropped their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. Evercore ISI reissued an “in-line” rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, BNP Paribas reissued an “outperform” rating and issued a $177.00 price objective on shares of Procter & Gamble in a research note on Friday, August 15th. Eleven investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $172.58.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.